SPH3348 Tablets

SPH3348 · Shanghai Pharmaceuticals Holding Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPH3348 Tablets, covering 2024-08-30 to 2024-08-30. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors [Phase 1]